MG1113, a specific anti-tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia

Kwak, H; Lee, S; Jo, S; Kwon, YE; Kang, H; Choi, G; Jung, ME; Kwak, MJ; Kim, S; Oh, BH; Kim, DS; Hwang, SH

Hwang, SH (corresponding author), GC Pharma, Dept Res & Early Dev, 93,Lhyeon Ro 30Beon-gil, Yongin 16924, Gyeonggi Do, South Korea.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020; 4 (8): 1301

Abstract

Background: Replacement therapy is the most common treatment for reduction of bleeding and control of episodic bleeding in individuals with hemophilia......

Full Text Link